Nitrogen
In clinical developmentAlso known as INOmax, N - Nitrogen, N2 - Nitrogen, Noxivent+1 more
INOmax, N - Nitrogen, N2 - Nitrogen, Noxivent, Ulspira.
Recent clinical, regulatory, research and industry developments relating to this drug.
The Role of Tidal Wetlands in the Global Nitrogen Cycle Under Global Change
Efficacy of Nitrous Oxide in OCD: Pilot Study
The microbial-driven nitrogen cycle and its relevance for plant nutrition.
Natural Compounds and Products from an Anti-Aging Perspective.
Nitrous Oxide for Posttraumatic Stress Disorder (PTSD): A Phase IIa Trial
Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- The Science of the total environment2
- Biological research1
- Global change biology1
- Journal of experimental botany1
- Molecules (Basel, Switzerland)1
- The ISME journal1
- Adeloye A1
- Ai S1
- Alduina R1
- Anas M1
- Badalucco L1
- Bing H1
- Bjørklund G1
- Blagodatskaya E1
- Aarhus University1
- Australian Rivers Institute1
- Banat's University of Agricultural Sciences and Veterinary Medicine "King Michael I of Romania" from Timisoara1
- Center for Health & Bioresources1
- Centre for AgriBioscience1
- College of Agriculture1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials